Last reviewed · How we verify
Ferumoxytol injection
Ferumoxytol injection is a Small molecule drug developed by University of Washington. It is currently FDA-approved. Also known as: Feraheme, FMX, Ferumoxytol, Feraheme™ (ferumoxytol) Injection.
Ferumoxytol injection, marketed by the University of Washington, is an iron replacement therapy with a key composition patent expiring in 2028. Its primary strength lies in its current market presence, leveraging its approved status and ongoing revenue generation. The primary risk is the potential increase in competition post-patent expiry in 2028.
At a glance
| Generic name | Ferumoxytol injection |
|---|---|
| Also known as | Feraheme, FMX, Ferumoxytol, Feraheme™ (ferumoxytol) Injection |
| Sponsor | University of Washington |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Ferumoxytol-enhanced Magnetic Resonance Venography in Patients With Venous Diseases (PHASE2)
- Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants (PHASE2)
- Handheld MPI Imaging to Track Stem Cells in Osteoarthritis (EARLY_PHASE1)
- A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma (PHASE1)
- Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient (PHASE3)
- Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRI (PHASE1)
- Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia (PHASE3)
- Advanced MRI for Uteroplacental Flow, Perfusion, Oxygenation & Inflammation
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ferumoxytol injection CI brief — competitive landscape report
- Ferumoxytol injection updates RSS · CI watch RSS
- University of Washington portfolio CI
Frequently asked questions about Ferumoxytol injection
What is Ferumoxytol injection?
Who makes Ferumoxytol injection?
Is Ferumoxytol injection also known as anything else?
What development phase is Ferumoxytol injection in?
Related
- Manufacturer: University of Washington — full pipeline
- Also known as: Feraheme, FMX, Ferumoxytol, Feraheme™ (ferumoxytol) Injection
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing